Strive Financial Group’s Pfizer PFE Stock Holding History

Strive Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$228K	Buy	9,474 +2,208	+30%	+$57.8K	0.1%	132
2026 Q1	$204K	Sell	7,266 -618	-8%	-$16.5K	0.11%	116
2025 Q4	$196K	Buy	+7,884	New	+$199K	0.1%	121

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Strive Financial Group's PFE Position: Q2 2026 in Review

Strive Financial Group increased its Pfizer (PFE) stake by 30% in Q2 2026, buying an estimated $57.8K and bringing the position to 9,474 shares worth $228K. The position accounts for 0.1% of the portfolio, ranked #132.

Strive Financial Group first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Strive Financial Group held 9,474 shares of Pfizer worth $228K as of Q2 2026.
Strive Financial Group bought 2,208 Pfizer shares in Q2 2026, an estimated $57.8K.
Pfizer made up 0.1% of Strive Financial Group's portfolio in Q2 2026, its #132 holding.
Strive Financial Group first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.